Biochemical Analysis Equipment-A series report on estimating the market size of medical device products in China

（ Year 2023）

01

Product brief Introduction

1.Product classification
According to NMPA 2017 Classification Catalogue of Medical Devices, biochemical analyzers belong to the 22nd major category of clinical testing instruments, with a management category of II.

On the track, biochemical analyzer belongs to the field of in vitro diagnosis – in vitro diagnostic instrument – biochemical diagnosis.

2. Application field

Biochemical diagnosis, also known as Clinical Chemistry, is often used for basic test items such as liver function, kidney function, blood sugar and blood lipid, that is, to determine whether the human body is in a healthy state and analyze the cause by measuring the content (or activity) of specific biochemical substances.

02

Development Driver

1. Policy Factor

   Since the “14th Five-Year Plan”, the National Health Commission and the National Development and Reform Commission have issued relevant policies and regulations for many times, listing diagnostic testing equipment as a key development field and vigorously developing the in vitro diagnosis industry. Among them, biochemical diagnosis, as the second largest market share of the in vitro diagnosis subdivision field, still cannot be completely replaced with its advantages of maturity, convenience and low cost.

2. Socioeconomic factors

After the outbreak of the novel coronavirus, China’s in vitro diagnosis industry has developed rapidly. By the end of 2022, there were 55 listed companies in vitro diagnosis in China, 29 of which were listed during the epidemic period. With the support of capital, domestic companies have broken through the technical barriers and many products have been approved for listing, driving the rapid development of the whole industry chain. China’s biochemical diagnostic technology is relatively mature, and the substitution ratio of domestic products is relatively high. The market growth mainly depends on the growing material and cultural needs of the people. In 2022, 548.73 million people underwent health check-ups, a year-on-year increase of 27.3%.

03

Market size
1.Calculation logic

List of enterprises identified: there are many market players in the field of biochemical analyzer in China. Major participants are Beckman, Mindray, Canon, Accu-chek, Dirui and other enterprises screened through Joinchain MDCLOUD.

Dismantling enterprise revenue: through public information to dismantle the revenue of listed enterprises, taking Accu-chek as an example, by dismantling revenue: to get the revenue of the diagnostic division, the proportion of business in Asia Pacific, the proportion of business in Asia Pacific China; combined with Joinchain MDCLOUD to dismantle the proportion of instruments and reagents, the proportion of biochemical analyzers in all biochemical analyzers, and finally get Accu-chek ‘s revenue of biochemical analyzers in China.

The results of integrated calculation are as follows: After disintegrating the revenue of all enterprises, MDCLOUD bidding data is used to analyze the market concentration and the proportion of each enterprise in this field, and the market size of chemiluminescence immunoanalyzer is obtained by synthesizing the above results.

2. Data basis

(1) Bidding data

The data range is the open bid-winning data of various medical institutions, scientific research institutions, testing institutions, universities and other institutions from 2019 to 2021; The data includes bid-winning time, bid-winning quantity, bid-winning price, bid-winning brand, bid-winning model, bid-winning unit, etc.

(2) Report of listed enterprises

It mainly includes the listing quarterly report, annual report, prospectus and other materials of major enterprises in this field.

(3) Market size forecasting

By calculating the market size of biochemical analyzer from 2019 to 2021, we assume that the market growth rate of biochemical analyzer will decrease slightly in the next four years and forecast that the market size of chemiluminescence immunoanalyzer will reach 4.075 billion yuan in 2025.

Figure 1 Market size of biochemical analytical instruments in China from 2019 to 2025E

Data：MDCLOUD

04

Market Pattern
According to calculation, CR4 in the field of biochemical analyzer in China in 2021 is 62.8%, and the market share of imported brands has further declined, with Mindray Medical accounting for one third of the market share and occupying the top spot.

Figure 2 Market share of biochemical analytical instruments in China in 2021

Source： MDCLOUD ，Joinchain Medical Device

Translated & edited ： Bradyknows